Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection

Edaravone, the first known free radical scavenger, has demonstrated cellular protective properties in animals and humans. Owing to its antioxidant activity, edaravone modulates oxidative damage in various diseases, especially neurodegenerative diseases. In 2015, edaravone was approved in Japan to tr...

Descripció completa

Dades bibliogràfiques
Autors principals:	Sun Joo Cha, Kiyoung Kim
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2022-01-01
Col·lecció:	Antioxidants
Matèries:	edaravone oxidative stress antioxidant mitochondria neurodegenerative disease amyotrophic lateral sclerosis
Accés en línia:	https://www.mdpi.com/2076-3921/11/2/195

Ítems similars

A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
per: Erdi Şahin
Publicat: (2018-03-01)

Edaravone: A new hope for patients with amyotrophic lateral sclerosis
per: Shivangi Garg, et al.
Publicat: (2019-01-01)

Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
per: Hideki Houzen, et al.
Publicat: (2021-07-01)

Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study
per: Jin-Mo Park, et al.
Publicat: (2022-07-01)

Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
per: Chang Liu, et al.
Publicat: (2024-10-01)

Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone
per: Hee Jo Han, et al.
Publicat: (2022-12-01)

New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments
per: Maria A. Lapshina, et al.
Publicat: (2023-11-01)

Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report
per: Kabindra Rai, et al.
Publicat: (2023-02-01)

The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
per: Jiantao Zhao, et al.
Publicat: (2022-06-01)

Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis
per: Hyun-Jun Choi, et al.
Publicat: (2020-09-01)

Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
per: Benjamin Rix Brooks, et al.
Publicat: (2022-10-01)

Iranian clinical practice guideline for amyotrophic lateral sclerosis
per: Reza Boostani, et al.
Publicat: (2023-06-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
per: Kamila Tuzim, et al.
Publicat: (2018-08-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
per: Kamila Tuzim, et al.
Publicat: (2018-08-01)

The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing
per: Aki Soejima-Kusunoki, et al.
Publicat: (2022-07-01)

Amyotrophic lateral sclerosis with frontotemporal dementia
per: Corina Roman-Filip, et al.
Publicat: (2010-09-01)

Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes
per: Eleonora Colombo, et al.
Publicat: (2023-10-01)

Advancements and challenges in amyotrophic lateral sclerosis
per: David Bradford, et al.
Publicat: (2024-05-01)

Intestinal Microbiota and Sclerosis Lateral Amyotrophic
per: Mariana Dantas de Carvalho Vilar, et al.
Publicat: (2022-03-01)

The implications of DNA methylation for amyotrophic lateral sclerosis
per: ADRIANA HELENA DE OLIVEIRA REIS, et al.
Publicat: (2023-10-01)

The role of statins in amyotrophic lateral sclerosis: protective or not?
per: Hayder M. Al-kuraishy, et al.
Publicat: (2024-06-01)

Evaluation of Sensory Nerve Conduction Abnormalities in Patients with Amyotrophic Lateral Sclerosis
per: Waseem H. Alkhaffaf
Publicat: (2021-06-01)

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
per: Frances Theunissen, et al.
Publicat: (2021-11-01)

Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704
per: Dong Wook Kang, et al.
Publicat: (2021-09-01)

Prevalence of amyotrophic lateral sclerosis in Latium region, Italy
per: Maria Puopolo, et al.
Publicat: (2021-12-01)

Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
per: Niccolò Candelise, et al.
Publicat: (2022-03-01)

Progress in the study of mitochondrial dysfunction in pathogenesis of amyotrophic lateral sclerosis
per: LIU Liyang, LIU Qing, LIU Yaping, ZHANG Xue
Publicat: (2023-02-01)

Amyotrophic lateral sclerosis: pathogenetic mechanisms and new approaches to pharmacotherapy (literature review)
per: T. M. Alekseeva, et al.
Publicat: (2019-01-01)

Commentary: Urinary Neopterin, a New Marker of the Neuroinflammatory Status in Amyotrophic Lateral Sclerosis
per: Gisele Espíndola, et al.
Publicat: (2021-03-01)

Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients
per: Swapnil Samadhiya, et al.
Publicat: (2022-01-01)

Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage
per: Marguerite Jamet, et al.
Publicat: (2024-03-01)

Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols
per: Anne Vejux, et al.
Publicat: (2018-01-01)

The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
per: Christoph Schweingruber, et al.
Publicat: (2022-08-01)

Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis
per: Mengli Wang, et al.
Publicat: (2021-06-01)

Depression in amyotrophic lateral sclerosis
per: Joanna Iłżecka
Publicat: (2021-10-01)

Amyotrophic lateral sclerosis : advances and perspectives of neuronanomedicine /
per: Machtoub, Lina, author, et al.
Publicat: (2016)

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
per: HaEun Cho, et al.
Publicat: (2020-12-01)

Staging model for amyotrophic lateral sclerosis in Singapore
per: Yuan Teck Tay, et al.
Publicat: (2022-07-01)

Analysis of SOD1 and C9orf72 mutations in patients with amyotrophic lateral sclerosis in Antioquia, Colombia
per: Jimena Jaramillo, et al.
Publicat: (2022-12-01)

Pain in Amyotrophic Lateral Sclerosis Is Underrated
per: Soyoung Kwak, et al.
Publicat: (2024-12-01)